Author:
Darcy Kathleen M.,Birrer Michael J.
Subject
Obstetrics and Gynaecology,Oncology
Reference59 articles.
1. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV epithelial ovarian cancer;McGuire;N Engl J Med,1996
2. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study;Farley;Cancer Res,2003
3. Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage and suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study;Darcy;Gynecol Oncol,2008
4. Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group study;Farley;Gynecol Oncol,2009
5. Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study;Darcy;Gynecol Oncol,2009
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献